Link to full articleThey found fragments of the key molecule, which they call virus-inhibitory peptide (VIRIP), are relatively abundant.
Tweaks to its amino acid components boosted its anti-HIV potency by two orders of magnitude.
Tests also showed that some derivatives of the molecule are highly stable in human blood plasma, and non-toxic even at very high concentrations.
A synthetic version of VIRIP also proved effective at blocking HIV, excluding the possibility that some other factor was responsible.
VIRIP targets a sugar molecule which HIV uses to infect a host cell.
If the technique does in fact work on HIV then variations should be possible on other viruses.